About 1 result found for searched term "BAY 73-6691" (0.128 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M7635 | BAY 73-6691 | PDE |
| (R)-BAY 73-6691 | ||
| BAY 73-6691 was characterized in vitro as the first potent and selective inhibitor of phosphodiesterase 9 (PDE9), which is currently under preclinical development for the treatment of Alzheimer′s disease. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
